noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Finance

Sheppard Mullin Richter & Hampton LLP

09/09/2025 | Press release | Distributed by Public on 09/09/2025 11:40

Sheppard Mullin Advised Celularity on Comprehensive Balance Sheet Restructuring and IP Monetization Strategy

Sheppard Mullin advised Celularity Inc. (Nasdaq: CELU), a leader in regenerative and cellular medicine, in its strategic and financial restructuring designed to significantly enhance liquidity and operational agility.

In this matter, Celularity successfully retired all debt obligations, including $32.0 million in senior secured loans and $9.6 million in accrued interest through a creative asset monetization structure. Sheppard Mullin's team structured an Asset Purchase Agreement under which Celularity sold its valuable intellectual property assets to Celeniv Pte. Ltd., and concurrently executed an exclusive License Agreement, enabling continued uninterrupted use of the assets. This approach preserved Celularity's operational capabilities while dramatically improving its financial flexibility.

The Sheppard Mullin team was led by the firm's co-leader of the Life Sciences team Jeffrey Fessler, partner Michael Orlando and associate Nazia Khan.

Read the full press release here.

Sheppard Mullin Richter & Hampton LLP published this content on September 09, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 09, 2025 at 17:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]